膜二層による表皮成長因子受容体の活性調節
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
細胞膜
科学分野:
- バイオ物理学
- 細胞生物学
- 生物化学
背景:
- 細胞表面受容体は,表皮成長因子受容体 (EGFR) のように,細胞外信号を細胞に伝達するために不可欠です.
- プラズマ膜の構成は 受容体の構造だけでなく 細胞の信号伝達に影響します
- 信号伝達における膜の役割の研究は複雑である.
研究 の 目的:
- 表皮成長因子受容体 (EGFR) のシグナル伝達における定義された膜組成の役割を調査する.
- EGFRの脂質依存型変化とシグナリング相互作用を特徴付ける.
- 膜脂質がEGFR活性を調節する生体物理的メカニズムを解明する.
主な方法:
- EGFRを含む特定の脂質の組成を持つナノディスクを作成するために,細胞フリー発現を利用した.
- リンガン誘発型変化とタンパク質の相互作用を分析するために単分子およびアンサンブル光測定法を使用した.
- 異なる脂質環境下での定量化されたATP結合および構成状態.
主要な成果:
- EGFRのトランスメブラン構造反応とシグナリングパートナーとの相互作用は,脂質組成に大きく依存する.
- がん細胞に多く見られるアニオン性脂質の含有量は,EGFRを活性化状態に保ち,リガンドなしでもシグナル伝達を促進した.
- コレステロールはEGFRの構成反応を抑制し,信号伝達に対する抑制効果を説明した.
結論:
- プラズマ膜の脂質環境は,EGFRシグナリングを制御するリガンド結合を覆すことができます.
- この脂質媒介による調節は 健全な細胞におけるEGFRの強固な活動と 癌のような疾患における異常な信号伝達の生体物理的基盤を提供する.
- 保存されたタンパク質配列は,活性膜調節が受容体チロシンキナーズの一般的な特徴であることを示唆する.
さらに関連する動画
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
8.8K
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
8.8K
関連する概念動画
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.3K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Receptor Tyrosine Kinases
14.0K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.0K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
